跳至主要内容
临床试验/ACTRN12613000895785
ACTRN12613000895785尚未招募未知

A pilot study to investigate the effects of one week of treatment with acetazolamide on the arterial levels of carbon dioxide in patients receiving non-invasive ventilation for the treatment of obesity hypoventilation syndrome

niversity of Otago, Wellington0 个研究点目标入组 10 人开始时间: 2013年8月12日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 99 Years(—)
性别
All

入选标准

  • Diagnosis of obesity hypoventilation syndrome
  • Currently receiving non-invasive ventilation in s-mode
  • No hospitalisation with decompensation of respiratory failure for at least 3 months
  • Willing and able to give informed consent

排除标准

  • Unable to provide informed consent
  • Poor renal function (eGFR <30ml/min)
  • Poor compliance with non-invasive ventilation (average usage less than 4 hours per night)
  • Allergy or previous adverse reaction to sulphur drugs
  • Use of supplemental oxygen
  • Any other safety concern at investigators discression

研究者

发起方
niversity of Otago, Wellington

相似试验